of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol).

AstraZeneca4,045 enrolled

Overview

An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.

Study Type

OBSERVATIONAL

Enrollment

4,045

Conditions

Low Density Lipoprotein Cholesterol Goal Achievement

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Subjects who was diagnosed as diabetes * Subjects who was diagnosed as dyslipidaemia or takes lipid lowering medication * Clinic visit in the past 6 months more than once Exclusion Criteria: * Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

Locations (22)

Research Site

Cheonan-si, Chungchungnam-do, South Korea

Research Site

Chuncheon, Gangwon-do, South Korea

Outcomes

Primary Outcomes

Investigate LDL-C goal achievement rate according to ADA recommendation

Time frame: Within the last 6 months from the date of data entry.

Secondary Outcomes

Investigate reduction of 10-year risk for CHD by using UKPDS risk engine

Time frame: Within the last 6 months from the date of data entry.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.